Abrysvo, the first vaccine against bronchiolitis, will soon be available

Abrysvo, the first vaccine against bronchiolitis, will soon be available

While the preventive treatment was made available in mid-September, this bronchiolitis vaccine will be available from winter 2024.

Finally, hope in the fight against bronchiolitis, a respiratory virus that affects one in three children every winter. After the arrival in mid-September of the preventive treatment Beyfortus, the first vaccine, called Abrysvofrom the Pfizer laboratory, will be available in winter 2024.

The new vaccine against bronchiolitis

Read also: What are the gestures of prevention against bronchiolitis in newborns?

Authorized at the end of July by the health authorities, this vaccine is intended for pregnant women in their third year of age trimester of pregnancy. “Vaccinated pregnant women produce antibodies that cross the placental barrier. Mothers pass them on therefore to fetuses who are therefore immune”, explained to BFMTV the virologist Marie-Anne Rameix-Weltiresearcher at the National Reference Center for Respiratory Viruses of the Institut Pasteur and the Inserm.

If this vaccine fails to prevent the contraction of bronchiolitis, it will limit its severe forms. It will protect children from birth to 6 months. It will also be aimed at people over the age of 60.

Bronchiolitis affects children under 2 years of age and is characterized by severe respiratory distress that causes coughing, rapid breathing, and wheezing. Which can quickly prove dangerous for children. Recall that it now affects ten French regions 480,000 cases per year.


What if the movie you were going to see tonight was a dump? Each week, Kalindi Ramphul gives you her opinion on which movie to see (or not) on the show The Only Opinion That Matters.

Source: Madmoizelle

Leave a Reply

Your email address will not be published. Required fields are marked *

Top Trending

Related POSTS